Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > FDA Coalition Seeks Increases to Agency Budget

Abstract:
The Coalition for a Stronger FDA commended HHS Secretary Michael Leavitt and FDA Commissioner
Andrew Von Eschenbach for increases in the Food and Drug Administration's fiscal year 2008 budget request and said it would work with Congress to include additional funding to ensure the agency is able to protect American patients and consumers.

FDA Coalition Seeks Increases to Agency Budget

Washington, DC | Posted on February 6th, 2007

"As a nation, we must make sure the FDA has sufficient resources to
protect the food supply while fulfilling its mission to review and approve
life-saving drug and medical device advances for patient use," said Tommy
G. Thompson, former Health and Human Services Secretary and co-chairman of
the Coalition. "This budget proposal is a good starting point in this tight
fiscal year, and we look forward to working with Congress to give the FDA
the additional funding it needs."
The Coalition said the administration's budget request includes
increases in the right areas, including strengthening food safety, at $10.6
million; modernizing drug safety, at $11.2 million; and medical device
safety and review, at $7.2 million.
The Coalition -- a diverse group of consumer, non-profit, patient and
industry groups -- is committed to building on these initial steps as
Congress works through the budget process in an attempt to give the FDA the
resources it needs. As part of a five-year process to significantly expand
the agency's budget, the Coalition is seeking $175 million in increases for
2008 over the fiscal year 2007 budget, including increases of $115 million
for food safety programs, $40 million for drug reviews, and $20 million for
medical device programs.
The increases will allow the FDA to build confidence in the public
health system, speed innovation in medical technology, ensure the United
States remains competitive in foreign markets, and boosts public confidence
in the agency and its mission.
Specifically, a $115 million increase in the food budget would allow
the FDA to:
-- Address gaps in food safety oversight with enhancements in inspection,
auditing, and compliance.

-- Promote health and wellness.

-- Speed approvals for safe new products and technologies for food.

-- Enhance scientific and policy programs, including risk assessment, risk
management, and analysis.

-- Promote globalization through harmonized, science-based food standards.

-- Provide leadership in food defense.

A $40 million increase in the drug budget would allow the FDA to:

-- Provide faster and safer approval of products that are saving lives and
transforming health care.

-- Promote new drug technologies that will revolutionize pharmaceutical
therapies and ensure continued U.S. leadership in drug innovation.

-- Enhance the surveillance capability over new drugs once they reach the
market.

-- Further integrate emerging science into the regulatory process.
A $20 million increase in the medical device budget would allow the FDA
to:
-- Provide at least current service funding to allow maintenance and
improvement of user fee performance goals.

-- Give FDA capability to oversee rapidly advancing technology in the
molecular medicine, wireless systems, robotics, minimally invasive
technologies, and nanotechnology fields. Fund Critical Path for
devices.

-- Maintain balance between user fees and appropriations to assure prompt
and effective approval process.
Bill Hubbard, a former FDA associate commissioner and now a senior
advisor to the Coalition, said the larger increases will ensure that more
modest gains aren't entirely dedicated to pay raises and inflationary
pressures.
"We are concerned that Congress is continually increasing the
responsibilities of FDA, without correspondingly increasing the
appropriations," Hubbard said. "Additional resources will build a solid
foundation for future increases that will help the FDA maintain and build
on its position as the world's foremost consumer protection organization."

####

About The Coalition for a Stronger FDA
The Coalition for a Stronger FDA is designed to be a multi-year effort
with the following goals: (1) making sure the FDA has sufficient resources
to protect patients and consumers and (2) maintaining public confidence and
trust in the FDA.
The Coalition plans to build public support for the FDA and work
productively with the executive branch and Congress to ensure the agency
has adequate resources to fulfill its mission. The Coalition welcomes and
seeks to work in concert with the important ongoing efforts of individuals,
companies, patient and consumer advocates and other groups to convince our
policymakers of the importance of increasing the FDA's entire budget,
including therapeutics, foods, cosmetics and medical products.
Tommy G. Thompson, Donna E. Shalala and Dr. Louis Sullivan -- the last
three Secretaries of the Department of Health and Human Services -- are the
co-chairs of the Coalition.
Member organizations of the Coalition include patient groups, consumer
advocates, public health organizations and innovative companies. A list of
members and more information on the Coalition can be found at
http://www.fdacoalition.org .

For more information, please click here

Contacts:
Ladd Wiley
Executive Director
1333 New Hampshire Avenue
NW, Suite 429
Washington DC, 20036
202-887-4211

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Safety-Nanoparticles/Risk management

First human trial shows ‘wonder’ material can be developed safely: A revolutionary nanomaterial with huge potential to tackle multiple global challenges could be developed further without acute risk to human health, research suggests February 16th, 2024

New research may make future design of nanotechnology safer with fewer side effects: Study shows a promising strategy to reduce adverse reactions to nanoparticles by using complement inhibitors October 6th, 2023

Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023

Billions of nanoplastics released when microwaving baby food containers: Exposure to plastic particles kills up to 75% of cultured kidney cells July 21st, 2023

Human Interest/Art

Drawing data in nanometer scale September 30th, 2022

Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022

Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021

JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project